Open for inclusion

Safety and pharmacokinetics of ODM-208 in patients with metastatic castration-resistant prostate cancer

Cancer type: Prostate cancer

Phase: I/II

Principal Investigator: Utriainen Tapio

Country: FI

Keywords: Finland, Helsinki

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03436485